News

NEW ONETOUCH VERIO® BLOOD GLUCOSE MONITORING SYSTEM HELPS PEOPLE WITH DIABETES BETTER UNDERSTAND THEIR BLOOD SUGAR TEST RESULTS WITH NO EXTRA WORK

Back

After One Week of Using the OneTouch Verio® Meter, 94% of Patients said it Makes Results Simple to Understand1  

Wayne, PA, Jan. 20, 2015 – LifeScan, Inc. has introduced the new OneTouch Verio® Blood Glucose Monitoring System that helps people with diabetes better understand their results without any extra effort. Easy to use, the OneTouch Verio® System features a color-coded range indicator that shows whether a test result is within, below or above the range limits set in the meter without the need to scroll or push buttons. It also looks for signs of progress and provides positive reinforcement with Progress Notes, which inform patients about the progress they are making in managing their diabetes and how often their blood glucose results are in range. After using the OneTouch Verio® Meter for a week, 94% of people with diabetes said it made their test results simple to understand.1  

“Nearly one third of people with diabetes say they can’t make sense of their blood sugar results2 and many may feel overwhelmed by too much information, information that isn't clear, or simply by the day-to-day effort required to manage diabetes,” said Dr. William Polonsky, Co-founder and President of the Behavioral Diabetes Institute. “The OneTouch Verio® Meter can help patients feel more confident about managing their blood sugar by providing helpful feedback about their results and opportunities for better control.”

The low and high range limits set in the OneTouch Verio® Meter can be customized for each patient based on their healthcare professional’s recommendations. With each test, the color-coded range indicator feature shows whether a result is below limit (blue), within range (green) or above the limit (red). When the meter displays a low result, it prompts the user to treat the low glucose result and retest in 15 minutes.

The OneTouch Verio® Meter also helps patients see their success by providing two types of Progress Notes. An “achievement” message is displayed when the current result is in range following three consecutive above range results. A “consistency” message appears when 70% of results in the past seven days are in range.

Currently, there are an estimated 29 million people with diabetes in the U.S. and many don’t test their blood sugar regularly or as recommended by their healthcare professional. Ninety-four percent (94%) of healthcare professionals surveyed believe the OneTouch Verio® Meter will help people feel more engaged in their care and will provide valuable information for those wanting to better manage their diabetes.3

OneTouch Verio® Meter Key Features:

  • Simple Testing: Test as you do now and get helpful information at a glance with no need to scroll or push buttons.  
  • Color-Coded Range Indicator: Makes it easy to immediately see if a blood sugar result is in or out of range.
  • Progress Notes: Automatic messages that let a patient know how they are doing. Examples: Treat Low Glucose message; Achievement and Consistency messages.
  • Automatic 7-day averages, 14-, 30- and 90-day averages also available.
  • High-resolution Color Display with large on-screen results.
  • Accurate Results: Meets the new ISO 15197:2013 standard for system accuracy.4
  • Uses OneTouch Verio® Test Strips: Requires a small amount of blood (0.4 ul) with easy application to either side of the test strip.
  • 500-test memory
  • Uses two replaceable AAA alkaline batteries, which are included with each System.

The OneTouch Verio® System is now available nationally wherever diabetes testing supplies are sold with an estimated retail price of $19.99. OneTouch® is the most recommended brand by endocrinologists and primary care physicians. OneTouch® Test Strips have the lowest co-pay on the most health plans* and are always covered by Medicare Part B. For more information about the OneTouch Verio® Meter and other OneTouch® Products, visit www.OneTouch.com.

About LifeScan:
With a vision of "creating a world without limits for people with diabetes," LifeScan, Inc. is a leading maker of blood glucose monitoring systems. In the U.S. OneTouch® Brand products are recommended by more endocrinologists and primary care physicians than any other brand. Globally, more than 10 million people depend on OneTouch® Brand products for simple testing and accurate results to help them manage their diabetes. For more information visit: www.OneTouch.com.

                                                                  # # #

*Some health plans may have more than one test strip covered at the lowest co-pay.

†Not a guarantee of coverage and payment. Coverage and payment may be subject to co-insurance, deductible, and patient eligibility requirements.

1 Study conducted in the UK and the US with 102 patients with diabetes. 2013.  

2 Survey of 18,457 U.S. diabetes patients who self-test their blood glucose, US Roper.  2011.

3 Clinical study conducted in 2012 in the U.S. with 64 Healthcare Professionals.

4 ISO 15197:2013 in vitro diagnostic test systems-Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus.

Back